Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Context Therapeutics Inc.

Clinical trials sponsored by Context Therapeutics Inc., explained in plain language.

Context Therapeutics Inc. CNTX NASDAQ

A clinical-stage biopharmaceutical company developing cancer therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1 Terminated 1

Double hormone blockade may tackle Hard-to-Treat breast cancer

Disease control Terminated

This trial tests a combination of two drugs, elacestrant and onapristone, in people with a specific type of advanced or metastatic breast cancer that is fueled by the hormones estrogen and progesterone. The goal is to see if blocking both hormone signals at once is safe and can s…

Phase: PHASE1, PHASE2 • Sponsor: Context Therapeutics Inc. • Aim: Disease control

Last updated Jul 23, 2026 00:00 UTC